Free Access
Med Sci (Paris)
Volume 31, Number 5, Mai 2015
Page(s) 546 - 550
Section M/S Revues
Published online 09 June 2015
  1. Grant BF. Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. J Subst Abuse 1995 ; 7 : 481–497. [CrossRef] [PubMed] [Google Scholar]
  2. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National comorbidity survey replication (NCS-R). JAMA 2003 ; 289 : 3095–3105. [CrossRef] [PubMed] [Google Scholar]
  3. Swendsen JD, Merikangas KR. The comorbidity of depression and substance use disorders. Clin Psychol Rev 2000 ; 20 : 173–189. [CrossRef] [PubMed] [Google Scholar]
  4. Vialou V. Dépression et régulation de l’activité dopaminergique. Med Sci (Paris) 2013 ; 29 : 473–477. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Volman SF, Lammel S, Margolis EB, et al. New insights into the specificity and plasticity of reward and aversion encoding in the mesolimbic system. J Neurosci 2013 ; 33 : 17569–76. [CrossRef] [PubMed] [Google Scholar]
  6. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006 ; 29 : 565–598. [CrossRef] [PubMed] [Google Scholar]
  7. Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci 2013 ; 14 : 609–625. [CrossRef] [PubMed] [Google Scholar]
  8. Der-Avakian A, Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci 2012 ; 35 : 68–77. [CrossRef] [PubMed] [Google Scholar]
  9. Bewernick BH, Hurlemann R, Matusch A, et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 2010 ; 67 : 110–116. [CrossRef] [PubMed] [Google Scholar]
  10. Kuhn J, Moller M, Treppmann JF, et al. Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction. Mol Psychiatry 2014 ; 19 : 145–146. [CrossRef] [Google Scholar]
  11. Aouizerate B, Martin-Guehl C, Cuny E, et al. Stimulation cérébrale profonde du striatum ventral dans le traitement du trouble obsessionnel-compulsif avec dépression majeure. Med Sci (Paris) 2005 ; 21 : 811–813. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  12. Zhou FM, Wilson CJ, Dani JA. Cholinergic interneuron characteristics and nicotinic properties in the striatum. J Neurobiol 2002 ; 53 : 590–605. [CrossRef] [PubMed] [Google Scholar]
  13. Lobo MK, Covington HE 3rd, Chaudhury D, et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 2010 ; 330 : 385–390. [CrossRef] [PubMed] [Google Scholar]
  14. Hikida T, Kimura K, Wada N, et al. Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 2010 ; 66 : 896–907. [CrossRef] [PubMed] [Google Scholar]
  15. Bertran-Gonzalez J, Bosch C, Maroteaux M, et al. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 2008 ; 28 : 5671–5685. [CrossRef] [PubMed] [Google Scholar]
  16. Svenningsson P, Chergui K, Rachleff I, et al. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 2006 ; 311 : 77–80. [CrossRef] [PubMed] [Google Scholar]
  17. Warner-Schmidt JL, Flajolet M, Maller A, et al. Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. J Neurosci 2009 ; 29 : 1937–1946. [CrossRef] [PubMed] [Google Scholar]
  18. Svenningsson P, Kim Y, Warner-Schmidt J, et al. p11 and its role in depression and therapeutic responses to antidepressants. Nat Rev Neurosci 2013 ; 14 : 673–680. [CrossRef] [PubMed] [Google Scholar]
  19. Alexander B, Warner-Schmidt J, Eriksson T, et al. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med 2010 ; 2 : 54ra76. [CrossRef] [Google Scholar]
  20. Warner-Schmidt JL, Schmidt EF, Marshall JJ, et al. Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior. Proc Natl Acad Sci USA 2012 ; 109 : 11360–5. [CrossRef] [Google Scholar]
  21. Le Moine C, Tison F, Bloch B. D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum. Neurosci Lett 1990 ; 117 : 248–252. [CrossRef] [PubMed] [Google Scholar]
  22. Nelson AB, Hang GB, Grueter BA, et al. A comparison of striatal-dependent behaviors in wild-type and hemizygous Drd1a and Drd2 BAC transgenic mice. J Neurosci 2012 ; 32 : 9119–9123. [CrossRef] [PubMed] [Google Scholar]
  23. Arango-Lievano M, Schwarz JT, Vernov M, et al. Cell-type specific expression of p11 controls cocaine reward. Biol Psychiatry 2014 ; 76 : 794–801. [CrossRef] [PubMed] [Google Scholar]
  24. Gong S, Doughty M, Harbaugh CR, et al. Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs. J Neurosci 2007 ; 27 : 9817–9823. [CrossRef] [PubMed] [Google Scholar]
  25. Chen G, Twyman R, Manji HK. p11 and gene therapy for severe psychiatric disorders: a practical goal? Sci Transl Med 2010 ; 2 : 54ps1. [CrossRef] [Google Scholar]
  26. Dugué GP, Tricoire L. Principes et applications de l’optogénétique en neuroscience. Med Sci (Paris) 2015 ; 31 : 291–303. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  27. Vandecasteele M, Senova YS, Palfi S, Dugué GP. Potentiel thérapeutique de la neuromodulation optogénétique. Med Sci (Paris) 2015 ; 31 : 404–416. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.